Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000186840 | SCV000240411 | uncertain significance | not provided | 2017-11-13 | criteria provided, single submitter | clinical testing | p.Arg517Stop (CGA>TGA): c.1549 C>T in exon 14 of the CACNB4 gene (NM_000726.2). The Arg517Stop nonsense variant in the CACNB4 gene has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. The variant may cause loss of normal protein function through protein truncation as the last four amino acids of the protein are lost; however, the affect of nonsense mutations at the end of the protein is unknown. Therefore, based on the currently available information, it is unclear whether Arg517Stop is a disease-causing mutation or a rare benign variant. The variant is found in EPILEPSY panel(s). |
Labcorp Genetics |
RCV000812419 | SCV000952730 | uncertain significance | Idiopathic generalized epilepsy | 2018-08-22 | criteria provided, single submitter | clinical testing | This sequence change results in a premature translational stop signal in the CACNB4 gene (p.Arg517*). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 4 amino acids of the CACNB4 protein. This variant is present in population databases (rs370263335, ExAC 0.03%). This variant has not been reported in the literature in individuals with CACNB4-related disease. ClinVar contains an entry for this variant (Variation ID: 204936). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |